[Lnc-TMEM132D-AS1 overexpression reduces sensitivity of non-small cell lung cancer cells to osimertinib].
Nan fang yi ke da xue xue bao = Journal of Southern Medical University（2023）
摘要
The expression of lnc-TMEM132D-AS1 is significantly upregulated in NSCLC cells with acquired osimertinib resistance, and may serve as a potential biomarker and therapeutic target for osimertinibresistant NSCLC.
更多查看译文
关键词
acquired drug resistance,lnc-TMEM132D-AS1,long non-coding RNA,non-small cell lung cancer,osimertinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要